Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice

Neurobiology of Disease

Volumn 77, Issue , 2015, Pages 238-245

  von Ruden E L ^a   Bogdanovic, R M ^a   Wotjak, C T ^b   Potschka, H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anandamide; Endocannabinoid system; Epileptogenesis; FAAH; Fatty acid amide hydrolase

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 [BIS(1,3 BENZODIOXOL 5 YL)HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; 1,3 BENZODIOXOLE DERIVATIVE; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN; PIPERIDINE DERIVATIVE;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; ENZYME INHIBITION; FOREBRAIN; KINDLING; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPORAL LOBE EPILEPSY; AMYGDALOID NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; EPILEPSY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REACTION TIME; TRANSGENIC MOUSE;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; BENZODIOXOLES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EPILEPSY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; KINDLING, NEUROLOGIC; MALE; MICE; MICE, TRANSGENIC; MONOACYLGLYCEROL LIPASES; PIPERIDINES; REACTION TIME; RECEPTOR, CANNABINOID, CB1;

EID: 84925798948     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.03.016     Document Type: Article

References (39)

1. Ameri A., Simmet T. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 361(3):265-272.
2. Bhaskaran M.D., Smith B.N. Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy. PLoS One 2010, 5(5):e10683.
3. Bidaut-Russell M., Devane W.A., Howlett A.C. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 1990, 55(1):21-26.
4. Deshpande L.S., Blair R.E., Ziobro J.M., Sombati S., Martin B.R., DeLorenzo R.J. Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur. J. Pharmacol. 2007, 558(1-3):52-59.
5. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(16):10819-10824.
6. Fezza F., Marrone M.C., Avvisati R., Di Tommaso M., Lanuti M., Rapino C., Mercuri N.B., Maccarrone M., Marinelli S. Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. Mol. Cell. Neurosci. 2014, 62:1-9.
7. Gao Y., Vasilyev D.V., Goncalves M.B., Howell F.V., Hobbs C., Reisenberg M., Shen R., Zhang M.Y., Strassle B.W., Lu P., Mark L., Piesla M.J., Deng K., Kouranova E.V., Ring R.H., Whiteside G.T., Bates B., Walsh F.S., Williams G., Pangalos M.N., Samad T.A., Doherty P. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 2010, 30(6):2017-2024.
8. Goldberg E.M., Coulter D.A. Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat. Rev. Neurosci. 2013, 14(5):337-349.
9. Guggenhuber S., Monory K., Lutz B., Klugmann M. AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity. PLoS One 2010, 5(12):e15707.
10. Hofmann M.E., Frazier C.J. Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Exp. Neurol. 2013, 244:43-50.
11. Jafari M., Soerensen J., Bogdanović R.M., Dimou L., Götz M., Potschka H. Long-term genetic fate mapping of adult generated neurons in a mouse temporal lobe epilepsy model. Neurobiol. Dis. 2012, 48(3):454-463.
12. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 2006, 26(21):5628-5637.
13. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29(3):717-727.
14. Lauckner J.E., Hille B., Mackie K. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11G proteins. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(52):19144-19149.
15. Lazenka M.F., Selley D.E., Sim-Selley L.J. Brain regional differences in CB1 receptor adaptation and regulation of transcription. Life Sci. 2013, 92(8-9):446-452.
16. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., Pavon F.J., Serrano A.M., Selley D.E., Parsons L.H., Lichtman A.H., Cravatt B.F. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 2009, 5(1):37-44.
17. Ma L., Wang L., Yang F., Meng X.-D., Wu C., Ma H., Jiang W. Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy. CNS Neurosci. Ther. 2014, 20(10):905-915.
18. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31(3):463-475.
19. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C., Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302(5642):84-88.
20. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wolfel B., Dodt H.U., Zieglgansberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsicano G., Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006, 51(4):455-466.
21. Moreira F.A., Aguiar D.C., Terzian A.L.B., Guimarães F.S., Wotjak C.T. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?. Neuroscience 2012, 204:186-192.
22. Naderi N., Ahmad-Molaei L., Aziz Ahari F., Motamedi F. Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat. Neurochem. Res. 2011, 36(8):1520-1525.
23. Paxinos G.U.C., Watson The rat brain in stereotactic coordinates 2005, Academic Press, Sydney.
24. Pekcec A., Muhlenhoff M., Gerardy-Schahn R., Potschka H. Impact of the PSA-NCAM system on pathophysiology in a chronic rodent model of temporal lobe epilepsy. Neurobiol. Dis. 2007, 27(1):54-66.
25. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32(3):281-294.
26. Ruehle S., Remmers F., Romo-Parra H., Massa F., Wickert M., Wörtge S., Häring M., Kaiser N., Marsicano G., Pape H.-C., Lutz B. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions. J. Neurosci. 2013, 33(25):10264-10277.
27. Schlosburg J.E., Blankman J.L., Long J.Z., Nomura D.K., Pan B., Kinsey S.G., Nguyen P.T., Ramesh D., Booker L., Burston J.J., Thomas E.A., Selley D.E., Sim-Selley L.J., Liu Q.S., Lichtman A.H., Cravatt B.F. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 2010, 13(9):1113-1119.
28. Sigel E., Baur R., Racz I., Marazzi J., Smart T.G., Zimmer A., Gertsch J. The major central endocannabinoid directly acts at GABA(A) receptors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(44):18150-18155.
29. Sugiura T., Kodaka T., Kondo S., Nakane S., Kondo H., Waku K., Ishima Y., Watanabe K., Yamamoto I. Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells. J. Biochem. 1997, 122(4):890-895.
30. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., Ishima Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 1999, 274(5):2794-2801.
31. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 2000, 275(1):605-612.
32. Sugiura T., Kishimoto S., Oka S., Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 2006, 45(5):405-446.
33. Tanimura A., Yamazaki M., Hashimotodani Y., Uchigashima M., Kawata S., Abe M., Kita Y., Hashimoto K., Shimizu T., Watanabe M., Sakimura K., Kano M. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 2010, 65(3):320-327.
34. Uchigashima M., Yamazaki M., Yamasaki M., Tanimura A., Sakimura K., Kano M., Watanabe M. Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus. J. Neurosci. 2011, 31(21):7700-7714.
35. von Rüden E.L., Jafari M., Bogdanovic R.M., Wotjak C.T., Potschka H. Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm. Neurobiol. Dis. 2015, 73:334-347.
36. Wendt H., Soerensen J., Wotjak C.T., Potschka H. Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice. Epilepsia 2011, 52(7):e62-e65.
37. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410(6828):588-592.
38. Wiskerke J., Irimia C., Cravatt B.F., De Vries T.J., Schoffelmeer A.N., Pattij T., Parsons L.H. Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study. ACS Chem. Neurosci. 2012, 3(5):407-417.
39. Yoshida T., Fukaya M., Uchigashima M., Miura E., Kamiya H., Kano M., Watanabe M. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 2006, 26(18):4740-4751.